Ruxolitinib for treating polycythaemia vera

Equality Impact Assessment (Guidance development) (PDF 157 KB)

Final draft guidance

Final draft guidance (PDF 329 KB)

Committee papers (PDF 1.51 MB)

Public committee slides (PDF 666 KB)

Final draft guidance Equality Impact Assessment (PDF 157 KB)

Draft guidance

Draft guidance (PDF version) (PDF 360 KB)

Committee papers (PDF 8.09 MB)

Public committee slides (PDF 672 KB)

Draft guidance (PDF version) Equality Impact Assessment (PDF 144 KB)

Draft guidance (online commenting)

Committee meeting: 2

Supporting documentation Register of Interests (PDF 266 KB)

Final scope (PDF 157 KB)

Final stakeholder list (PDF 163 KB)

NICE's response to comments on the draft scope and provisional stakeholder list (PDF 182 KB)

Equality impact assessment (Scoping) (PDF 125 KB)

Draft scope post referral (PDF 168 KB)

Draft matrix post referral (PDF 156 KB)

Final scope TA356 (PDF 93 KB)

Final stakeholder list TA356 (MSWord 33 KB)

NICE's response to comments on the draft scope and provisional stakeholder list TA356 (PDF 122 KB)

Equality impact assessment (Scoping) TA356 (PDF 63 KB)

Draft scope pre referral TA356 (PDF 103 KB)

Draft matrix pre referral TA356 (PDF 38 KB)